[Continued gastric acid inhibitory therapy after Helicobacter eradication?].
Mössner
J
J
Medizinische Klinik und Poliklinik II, Universität, Leipzig.
D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000209:etiology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D012307:Risk Factors; D016896:Treatment Outcome
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists
Fortgesetzte Säuresekretionshemmende Therapie nach Helicobacter Eradikation?